Hydrocortison-Vaselinecrème Fna Dmb (Hydrocortisone Acetate)

Hydrocortison‑Vaselinecrème Fna Dmb is used to manage several inflammatory skin disorders where topical corticosteroid therapy is appropriate.

• Eczema (atopic dermatitis) affecting mild to moderate areas.
• Contact dermatitis caused by irritants or allergens.
• Psoriasis plaques that respond to low‑potency corticosteroids.
• Seborrheic dermatitis of the scalp or face.
• Other localized inflammatory skin conditions as determined by a clinician.

• Hydrocortisone acetate penetrates the epidermis and binds to intracellular glucocorticoid receptors. The receptor‑ligand complex translocates to the nucleus, where it interacts with glucocorticoid response elements and modulates transcription of inflammatory genes. This results in decreased synthesis of prostaglandins, cytokines, and other mediators, while also inhibiting leukocyte migration, thereby producing anti‑inflammatory and immunosuppressive effects at the site of application and promotes vasoconstriction, which further reduces edema.

Topical application of hydrocortisone acetate may cause local skin reactions, most of which are mild and reversible.

Common

• Mild burning or stinging at the application site.
• Transient itching or redness.
• Dryness or peeling of the treated skin.
• Slight skin thinning with prolonged use.

Serious

• Allergic contact dermatitis manifesting as rash or swelling.
• Significant skin atrophy or striae.
• Secondary bacterial, fungal, or viral infection of the area.
• Systemic absorption leading to adrenal suppression (rare with extensive use).

Before using Hydrocortison‑Vaselinecrème Fna Dmb, certain safety considerations should be observed to minimize risks.

• Avoid application to broken, infected, or ulcerated skin unless directed by a physician.
• Do not use on the face, groin, or axillae for prolonged periods without medical supervision.
• Limit treatment duration, typically not exceeding two weeks, to reduce the risk of skin atrophy.
• Discontinue use and seek medical advice if signs of an allergic reaction develop.
• Use caution in children, pregnant or breastfeeding individuals; consult a healthcare professional first.
• Keep the product out of reach of children and store at room temperature away from direct sunlight.

Hydrocortison‑Vaselinecrème Fna Dmb can interact with other topical agents or systemic medications that affect corticosteroid activity.

Avoid

• Concurrent use of other potent topical corticosteroids on the same area.
• Application of occlusive dressings that increase systemic absorption.

Use with caution

• Systemic corticosteroids, which may enhance adrenal suppression.
• Antifungal or antibacterial creams that could irritate the skin when combined.
• Drugs that affect wound healing, such as retinoids or vitamin A derivatives.
• Herbal or over‑the‑counter skin products containing irritants.